Addus HomeCare Analyst Price Targets

Wall Street analyst price targets and consensus rating for Addus HomeCare (ADUS).

Price Target Range — 12 Quarters

Analyst Consensus — 13 Analysts

2S.Buy

8Buy

2Hold

1Sell

Consensus RatingOverweight# Analysts13Avg. Consensus PT$138Upside to Avg. PT+9.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 14, 2026	B of A Securities	Joanna Gajuk	Downgrade	Buy→Neutral	$140→$125
Aug 5, 2026	RBC Capital	Ben Hendrix	PT Raise	Outperform	$130→$134
Jul 9, 2026	Barclays	Andrew Mok	PT Raise	Underweight	$92→$96
May 18, 2026	Citizens	Constantine Davides	Maintained	Market Outperform	$142
May 15, 2026	Barclays	Andrew Mok	PT Cut	Underweight	$102→$92
May 6, 2026	Citizens	Constantine Davides	PT Cut	Market Outperform	$150→$142
Mar 25, 2026	Barclays	Andrew Mok	PT Cut	Underweight	$112→$102
Feb 25, 2026	Stephens & Co.	Scott Fidel	PT Cut	Overweight	$140→$135
Feb 24, 2026	Barclays	Andrew Mok	PT Cut	Underweight	$117→$112
Nov 13, 2025	BMO Capital	Sean Dodge	Initiate	Market Perform	$120
Nov 7, 2025	RBC Capital	Ben Hendrix	PT Raise	Outperform	$134→$139
Nov 5, 2025	TD Cowen	Ryan Langston	PT Raise	Buy	$139→$140
Nov 4, 2025	Barclays	Andrew Mok	PT Raise	Underweight	$111→$117
Sep 3, 2025	Stephens & Co.	Raj Kumar	Maintained	Overweight	$140
Sep 2, 2025	UBS	A.J. Rice	Initiate	Buy	$145
Aug 22, 2025	RBC Capital	Ben Hendrix	PT Raise	Outperform	$133→$134
Aug 19, 2025	Barclays	Andrew Mok	PT Raise	Underweight	$83→$109
Aug 6, 2025	TD Cowen	Ryan Langston	PT Raise	Buy	$135→$139
Jul 31, 2025	RBC Capital	Ben Hendrix	PT Cut	Outperform	$136→$133
Jul 16, 2025	JMP Securities	Constantine Davides	Maintained	Market Outperform	$150

Analyst Ratings News

This Charter Communications Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

Analysts downgraded ADUS, HPE, ERII, CHTR and CCI; targets fell for ADUS and CCI, while CHTR received a $118 target.

Avi Kapoor

PRO
B of A Securities Downgrades Addus HomeCare to Neutral, Lowers Price Target to $125

B of A Securities analyst Joanna Gajuk downgrades Addus HomeCare (NASDAQ:ADUS) from Buy to Neutral and lowers the price target from $140 to $125.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Addus HomeCare, Raises Price Target to $134

RBC Capital analyst Ben Hendrix maintains Addus HomeCare (NASDAQ:ADUS) with a Outperform and raises the price target from $130 to $134.

Benzinga Newsdesk

PRO
Barclays Maintains Underweight on Addus HomeCare, Raises Price Target to $96

Barclays analyst Andrew Mok maintains Addus HomeCare (NASDAQ:ADUS) with a Underweight and raises the price target from $92 to $96.

Benzinga Newsdesk

PRO
Citizens Reiterates Market Outperform on Addus HomeCare, Maintains $142 Price Target

Citizens analyst Constantine Davides reiterates Addus HomeCare (NASDAQ:ADUS) with a Market Outperform and maintains $142 price target.

Benzinga Newsdesk

PRO
Barclays Maintains Underweight on Addus HomeCare, Lowers Price Target to $92

Barclays analyst Andrew Mok maintains Addus HomeCare (NASDAQ:ADUS) with a Underweight and lowers the price target from $102 to $92.

Benzinga Newsdesk

Addus HomeCare Corp

Addus HomeCare Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Charter Communications Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

PRO
B of A Securities Downgrades Addus HomeCare to Neutral, Lowers Price Target to $125

PRO
RBC Capital Maintains Outperform on Addus HomeCare, Raises Price Target to $134

PRO
Barclays Maintains Underweight on Addus HomeCare, Raises Price Target to $96

PRO
Citizens Reiterates Market Outperform on Addus HomeCare, Maintains $142 Price Target

PRO
Barclays Maintains Underweight on Addus HomeCare, Lowers Price Target to $92

People Also Watch

People Also Watch

Addus HomeCare Corp

Addus HomeCare Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Charter Communications Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

PROB of A Securities Downgrades Addus HomeCare to Neutral, Lowers Price Target to $125

PRORBC Capital Maintains Outperform on Addus HomeCare, Raises Price Target to $134

PROBarclays Maintains Underweight on Addus HomeCare, Raises Price Target to $96

PROCitizens Reiterates Market Outperform on Addus HomeCare, Maintains $142 Price Target

PROBarclays Maintains Underweight on Addus HomeCare, Lowers Price Target to $92

People Also Watch

People Also Watch

PRO
B of A Securities Downgrades Addus HomeCare to Neutral, Lowers Price Target to $125

PRO
RBC Capital Maintains Outperform on Addus HomeCare, Raises Price Target to $134

PRO
Barclays Maintains Underweight on Addus HomeCare, Raises Price Target to $96

PRO
Citizens Reiterates Market Outperform on Addus HomeCare, Maintains $142 Price Target

PRO
Barclays Maintains Underweight on Addus HomeCare, Lowers Price Target to $92